The veteran's prostate cancer and peripheral neuropathy were not incurred in or aggravated by service, nor may they be presumed related to service.
The deciding factor: The evidence does not support a finding that the veteran's prostate cancer or peripheral neuropathy are related to his military service, including any exposure to herbicides such as Agent Orange.
- Claimed conditions
- Prostate cancer, Peripheral neuropathy
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- January 8, 2009
- Citation
- 0900765
What this means for you
A denial is a starting point, not the end of the road. You can see why this claim fell short — and, if you are still inside the one-year window, the appeal lanes that may remain open to you.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Board restored the Veteran's 100 percent disability rating for his service-connected prostate cancer, effective September 1, 2024.
- Partly granted
The Board denied a higher disability rating for PTSD and granted service connection for lumbosacral strain, while denying service connection for prostate cancer, erectile dysfunction, hypertension, and nuclear sclerosis and dry eye syndrome.
- Dismissed
The appeals for service connection and higher initial rating were dismissed due to concurrent election of review options.
- Granted
The Veteran is granted a total disability rating based on individual unemployability (TDIU) and an effective date of August 13, 2019, for the grant of Special Monthly Compensation (SMC) based on the need for aid and attendance.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.